


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-10.95%
+2.43%
+1.62%
+34.90%
+2.13%
AVXL
Anavex Life Sciences
$4.11
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
AVXL Price Performance
$3.65 (+12.60%)
$8.67 (-52.60%)
$13.41 (-69.35%)
$12.56 (-67.28%)
AVXL has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

AVXL overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
AVXL Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
AVXL Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is AVXL current stock price?
What are AVXL stock strengths?
What is AVXL Risk Level?
What is AVXL market cap and volume?
What is AVXL current Stock IQ?
Should I buy AVXL stock right now?
Is AVXL a Strong Buy right now?
What does a 'Strong Buy' rating mean for AVXL?
What does a 'Strong Sell' rating mean for AVXL?
What factors influence AVXL's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-10.95%
+2.43%
+1.62%
+34.90%
+2.13%
AVXL
Anavex Life Sciences
Current Price
$4.11
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

AVXL Price Performance
$3.65 (+12.60%)
$8.67 (-52.60%)
$13.41 (-69.35%)
$12.56 (-67.28%)
AVXL Analysts Opinion
AVXL Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
AVXL Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
AVXL Street Sentiment is extremely bullish and have negative views on the near-term outlook
AVXL has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Average key support and resistance price levels
AVXL Stock IQ
AVXL Latest Analysis
Anavex Life Sciences Corp. (AVXL) Presents at 18th Clinical Trials on Alzheimers Disease (CTAD-25) Conference - Slideshow.
Wed Dec 3, 2025
Down 50.7% in 4 Weeks Heres Why You Should You Buy the Dip in Anavex Life Sciences (AVXL). Anavex Life Sciences (AVXL) has become technically an oversold stock now which implies exhaustion of the heavy selling pressure on it. This combined with strong agreement among Wall Street analysts in revising earnings estimates higher indicates a potential trend reversal for the stock in the near term.
Tue Dec 2, 2025
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q4 2025 Earnings Call Transcript. Anavex Life Sciences Corp. (NASDAQ:AVXL) Q4 2025 Earnings Call Transcript November 25 2025 Anavex Life Sciences Corp. beats earnings expectations. Reported EPS is $-0.11 expectations were $-0.13. Clint Tomlinson: Good morning everyone and welcome to the Anavex Life Sciences Fiscal 2025 Fourth Quarter Conference Call. My name is Clint Tomlinson and I’.ll be your host [….]
Wed Nov 26, 2025
A Preview Of Anavex Life Sciencess Earnings. Anavex Life Sciences (NASDAQ:AVXL) is preparing to release its quarterly earnings on Tuesday 2025-11-25. Here'.s a brief overview of what investors should keep in mind before the announcement.Analysts expect Anavex Life Sciences to report an Anavex Life Sciences s will hope to hear the company announce they'.ve not only beaten that estimate but also to provide positive guidance or forecasted growth for the next quarter.New investors ...
Mon Nov 24, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
AVXL Stock trends
AVXL Stock performance
AVXL Stock analysis
AVXL investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.